{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:56:26Z","timestamp":1777650986842,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,7,30]],"date-time":"2011-07-30T00:00:00Z","timestamp":1311984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00408-011-9311-6","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T10:35:41Z","timestamp":1311935741000},"source":"Crossref","is-referenced-by-count":7,"title":["Improved Outcomes of Patients with End-stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure"],"prefix":"10.1007","volume":"189","author":[{"suffix":"Jr.","given":"Don","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,30]]},"reference":[{"key":"9311_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/apa.1989.78.s363.25","volume":"363","author":"TF Boat","year":"1989","unstructured":"Boat TF, Cheng PW (1989) Epithelial cell dysfunction in cystic fibrosis: implications for airways disease. Acta Paediatr Scand Suppl 363:25\u201329; discussion 29\u201330","journal-title":"Acta Paediatr Scand Suppl"},{"issue":"6","key":"9311_CR2","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI2687","volume":"102","author":"H Matsui","year":"1998","unstructured":"Matsui H, Randell SH, Peretti SW, Davis CW, Boucher RC (1998) Coordinated clearance of periciliary liquid and mucus from airway surfaces. J Clin Invest 102(6):1125\u20131131","journal-title":"J Clin Invest"},{"key":"9311_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1526-0550(02)00005-7","volume":"3","author":"E Puchelle","year":"2002","unstructured":"Puchelle E, Bajolet O, Ab\u00e9ly M (2002) Airway mucus in cystic fibrosis. Paediatr Respir Rev 3:115\u2013119","journal-title":"Paediatr Respir Rev"},{"key":"9311_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jcf.2010.03.001","volume":"9","author":"M Ulrich","year":"2010","unstructured":"Ulrich M, Worlitzsch D, Viglio S et al (2010) Alveolar inflammation in cystic fibrosis. J Cyst Fibros 9:217\u2013227","journal-title":"J Cyst Fibros"},{"key":"9311_CR5","first-page":"45","volume-title":"Cystic fibrosis in adults","author":"PB Davis","year":"1999","unstructured":"Davis PB (1999) Clinical pathophysiology and manifestations of lung disease. In: Yankaskas JR, Knowles MR (eds) Cystic fibrosis in adults, 1st edn. Lippincott-Raven, Philadelphia, pp 45\u201367","edition":"1"},{"key":"9311_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jama.239.18.1851","volume":"239","author":"PB Davis","year":"1974","unstructured":"Davis PB, di Sant\u2019Agnese PA (1974) Assisted ventilation for patients with cystic fibrosis. JAMA 239:1851\u20131854","journal-title":"JAMA"},{"key":"9311_CR7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1542\/peds.53.5.678","volume":"53","author":"JD Lloyd-Still","year":"1974","unstructured":"Lloyd-Still JD, Khaw KT, Shwachman H (1974) Severe respiratory disease in infants with cystic fibrosis. Pediatrics 53:678\u2013682","journal-title":"Pediatrics"},{"key":"9311_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1378\/chest.96.1.136","volume":"96","author":"JS Garland","year":"1989","unstructured":"Garland JS, Chan YM, Kelly KJ, Rice TB (1989) Outcome of infants with cystic fibrosis requiring mechanical ventilation for respiratory failure. Chest 96:136\u2013138","journal-title":"Chest"},{"key":"9311_CR9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1164\/ajrccm.163.2.2003076","volume":"163","author":"N Sood","year":"2001","unstructured":"Sood N, Paradowski LJ, Yankaskas JR (2001) Outcomes of intensive care unit care in adults with cystic fibrosis. Am J Respir Crit Care Med 163:335\u2013338","journal-title":"Am J Respir Crit Care Med"},{"key":"9311_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ppul.10159","volume":"34","author":"A Berlinski","year":"2002","unstructured":"Berlinski A, Fan LL, Kozinetz CA, Oermann CM (2002) Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. Pediatr Pulmonol 34:297\u2013303","journal-title":"Pediatr Pulmonol"},{"key":"9311_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcf.2003.12.003","volume":"3","author":"H Vedam","year":"2004","unstructured":"Vedam H, Moriarty C, Torzillo PJ, McWilliam D, Bye PT (2004) Improved outcomes of patients with cystic fibrosis admitted to the intensive care unit. J Cyst Fibros 3:8\u201314","journal-title":"J Cyst Fibros"},{"key":"9311_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s00134-006-0085-x","volume":"32","author":"MG Slieker","year":"2006","unstructured":"Slieker MG, van Gestel JP, Heijerman HG et al (2006) Outcome of assisted ventilation for acute respiratory failure in cystic fibrosis. Intensive Care Med 32:754\u2013758","journal-title":"Intensive Care Med"},{"key":"9311_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0022-3476(98)70344-0","volume":"132","author":"BJ Rosenstein","year":"1998","unstructured":"Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589\u2013595","journal-title":"J Pediatr"},{"key":"9311_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00006454-198707000-00006","volume":"6","author":"R Padoan","year":"1987","unstructured":"Padoan R, Cambisano W, Costantini D et al (1987) Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis. Pediatr Infect Dis J 6:648\u2013653","journal-title":"Pediatr Infect Dis J"},{"key":"9311_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/clpt.1984.187","volume":"36","author":"JS Leeder","year":"1984","unstructured":"Leeder JS, Spino M, Isles AF, Tesoro AM, Gold R, MacLeod SM (1984) Ceftazidime disposition in acute and stable cystic fibrosis. Clin Pharmacol Ther 36:355\u2013362","journal-title":"Clin Pharmacol Ther"},{"key":"9311_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/PL00008370","volume":"159","author":"I Rappaz","year":"2000","unstructured":"Rappaz I, Decosterd LA, Bille J, Pilet M, B\u00e9laz N, Roulet M (2000) Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children. Eur J Pediatr 159:919\u2013925","journal-title":"Eur J Pediatr"},{"key":"9311_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/BF01963774","volume":"8","author":"R Roosendaal","year":"1989","unstructured":"Roosendaal R, Bakker-Woudenberg IA, Van den Berghe Van-Raffe M, Vink-van den Berg JC, Michel BM (1989) Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. Eur J Clin Microbiol Infect Dis 8:878\u2013887","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9311_CR18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AAC.36.12.2577","volume":"36","author":"WA Craig","year":"1992","unstructured":"Craig WA, Ebert SC (1992) Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 36:2577\u20132583","journal-title":"Antimicrob Agents Chemother"},{"key":"9311_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF02310354","volume":"14","author":"S Daenen","year":"1995","unstructured":"Daenen S, Erjavec Z, Uges DR, De Vries-Hospers HG, De Jonge P, Halie MR (1995) Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia. Eur J Clin Microbiol Infect Dis 14:188\u2013192","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"9311_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/AAC.40.1.61","volume":"40","author":"DP Nicolau","year":"1996","unstructured":"Nicolau DP, Nightingale CH, Banevicius MA, Fu Q, Quintiliani R (1996) Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections. Antimicrob Agents Chemother 40:61\u201364","journal-title":"Antimicrob Agents Chemother"},{"issue":"5 Pt 2","key":"9311_CR21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-3476(86)80754-5","volume":"108","author":"B Vogelman","year":"1986","unstructured":"Vogelman B, Craig WA (1986) Kinetics of antimicrobial activity. J Pediatr 108(5 Pt 2):835\u2013840","journal-title":"J Pediatr"},{"key":"9311_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/106002809502900413","volume":"29","author":"TG Vondracek","year":"1995","unstructured":"Vondracek TG (1995) Beta-lactam antibiotics: is continuous infusion the preferred method of administration? Ann Pharmacother 29:415\u2013424","journal-title":"Ann Pharmacother"},{"key":"9311_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijantimicag.2006.02.020","volume":"28","author":"MR Rafati","year":"2006","unstructured":"Rafati MR, Rouini MR, Mojtahedzadeh M et al (2006) Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. Int J Antimicrob Agents 28:122\u2013127","journal-title":"Int J Antimicrob Agents"},{"key":"9311_CR24","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/AAC.00329-06","volume":"50","author":"WK Lau","year":"2006","unstructured":"Lau WK, Mercer D, Itani KM et al (2006) Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection. Antimicrob Agents Chemother 50:3556\u20133561","journal-title":"Antimicrob Agents Chemother"},{"key":"9311_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijantimicag.2007.02.002","volume":"30","author":"JA Roberts","year":"2007","unstructured":"Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30:11\u201318","journal-title":"Int J Antimicrob Agents"},{"key":"9311_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1097\/CCM.0b013e3181a0054d","volume":"37","author":"JA Roberts","year":"2009","unstructured":"Roberts JA, Webb S, Paterson D, Ho KM, Lipman J (2009) A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 37:2071\u20132078","journal-title":"Crit Care Med"},{"key":"9311_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s15010-009-8116-5","volume":"37","author":"J Riethmueller","year":"2009","unstructured":"Riethmueller J, Junge S, Schroeter TW et al (2009) Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis. Infection 37:418\u2013423","journal-title":"Infection"},{"key":"9311_CR28","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1128\/AAC.00174-09","volume":"53","author":"D Hubert","year":"2009","unstructured":"Hubert D, Le Roux E, Lavrut T et al (2009) Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis. Antimicrob Agents Chemother 53:3650\u20133656","journal-title":"Antimicrob Agents Chemother"},{"key":"9311_CR29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1179\/joc.1995.7.4.338","volume":"7","author":"F Paradisi","year":"1995","unstructured":"Paradisi F, Corti G (1995) Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections. J Chemother 7:338\u2013343","journal-title":"J Chemother"},{"key":"9311_CR30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/infdis\/147.5.918","volume":"147","author":"SH Powell","year":"1983","unstructured":"Powell SH, Thompson WL, Luthe MA et al (1983) Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis 147:918\u2013932","journal-title":"J Infect Dis"},{"key":"9311_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1378\/chest.112.5.1208","volume":"112","author":"RD Bates","year":"1997","unstructured":"Bates RD, Nahata MC, Jones JW et al (1997) Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis. Chest 112:1208\u20131213","journal-title":"Chest"},{"key":"9311_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/jac\/42.1.103","volume":"42","author":"R Bragonier","year":"1998","unstructured":"Bragonier R, Brown NM (1998) The pharmacokinetics and toxicity of once-daily tobramycin therapy in children with cystic fibrosis. J Antimicrob Chemother 42:103\u2013106","journal-title":"J Antimicrob Chemother"},{"key":"9311_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/adc.78.6.536","volume":"78","author":"P Vic","year":"1998","unstructured":"Vic P, Ategbo S, Turck D et al (1998) Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis. Arch Dis Child 78:536\u2013539","journal-title":"Arch Dis Child"},{"key":"9311_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jac\/dkf168","volume":"50","author":"A Aminimanizani","year":"2002","unstructured":"Aminimanizani A, Beringer PM, Kang J, Tsang L, Jelliffe RW, Shapiro BJ (2002) Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis. J Antimicrob Chemother 50:553\u2013559","journal-title":"J Antimicrob Chemother"},{"key":"9311_CR35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)70798-4","volume":"365","author":"A Smyth","year":"2005","unstructured":"Smyth A, Tan KH, Hyman-Taylor P et al (2005) Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis\u2013the TOPIC study: a randomised controlled trial. Lancet 365:573\u2013578","journal-title":"Lancet"},{"key":"9311_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s15010-009-8117-4","volume":"37","author":"J Riethmueller","year":"2009","unstructured":"Riethmueller J, Ballmann M, Schroeter TW et al (2009) Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients. Infection 37:424\u2013431","journal-title":"Infection"},{"key":"9311_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/jac\/dkl328","volume":"58","author":"O Burkhardt","year":"2006","unstructured":"Burkhardt O, Lehmann C, Madabushi R, Kumar V, Derendorf H, Welte T (2006) Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? J Antimicrob Chemother 58:822\u2013829","journal-title":"J Antimicrob Chemother"},{"key":"9311_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1445-5994.2008.01787.x","volume":"39","author":"N Soulsby","year":"2009","unstructured":"Soulsby N, Bell S, Greville H, Doecke C (2009) Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What\u2019s new? Intern Med J 39:527\u2013531","journal-title":"Intern Med J"},{"key":"9311_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1592\/phco.30.1.95","volume":"30","author":"WA Prescott Jr","year":"2010","unstructured":"Prescott WA Jr, Nagel JL (2010) Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis. Pharmacotherapy 30:95\u2013108","journal-title":"Pharmacotherapy"},{"key":"9311_CR40","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","volume":"114","author":"DG Contopoulos-Ioannidis","year":"2004","unstructured":"Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP (2004) Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics 114:e111\u2013e118","journal-title":"Pediatrics"},{"key":"9311_CR41","unstructured":"Smyth AR, Bhatt J (2010) Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev (1):CD002009"},{"key":"9311_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","volume":"180","author":"PA Flume","year":"2009","unstructured":"Flume PA, Mogayzel PJ Jr, Robinson KA et al (2009) Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 180:802\u2013808","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-011-9311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-011-9311-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-011-9311-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-011-9311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T12:52:49Z","timestamp":1686228769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-011-9311-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,30]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9311"],"URL":"https:\/\/doi.org\/10.1007\/s00408-011-9311-6","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,30]]},"article-number":"409"}}